NIH halts trial of hydroxychloroquine | TheHill
The National Institutes of Health (NIH) has halted its clinical trial of hydroxychloroquine, saying that while there are no ill side effects, the anti-Malaria drug provides no benefit to COVID-19 patients.”A data and safety monitoring board (DSMB) met late Friday and determined that while there was no harm, the study drug was very unlikely to be beneficial to…